Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease

NCT03159091 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

238

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Rengalin
DRUG: Placebo

Sponsor

Materia Medica Holding